.

Previous Requests Log - March 2017

Date Reference

Question(s)

Response 
01/03/2017 533/17

1. The total expenditure that has been incurred on:

a. Consultants (other than NHS staff) – broken down by firm (and project type if available)
b. On NHS staff, and
c. On other running costs - broken down by category (e.g. logo design, printing, catering, engagement materials), for the production of the Derbyshire Sustainability and Transformation Plan from 1 January 2016 to date.

2. The budget for each of these three items for the financial year 2017/2018.

Click here for Response
01/03/2017 534/17

1. Please could you provide the number of adults funded by the CCG requiring neuro-rehabilitation during the financial year?

2. Of the total number of adults requiring neuro-rehabilitation funded by your CCG (Q.1), how many did receive support in a Level 2a or Level 2b rehabilitation service (as defined by the British Society of Rehabilitation Medicine: Specialised Neuro-rehabilitation Service Standards 7, 30th April 2015)? If number smaller than 5, please indicate with *.

3. Please provide the CCG's total expenditure on neuro-rehabilitation placements for the financial years 2013/14, 2014/15, and 2015/16.

4. How much of the total expenditure (Q.3) was spent with Level 2a and Level 2b rehabilitation services?

5. To how many commissioned total commissioned bed days did the expenditure (Q.4) on Level 2a and Level 2b rehabilitation services correlate?

6. Please provide a list of the providers that you commissioned neuro-rehabilitation Level 2a and Level 2b services with.

7. Please could you provide the number of adults funded by the CCG requiring neuro-rehabilitation in a Level 3 rehabilitation service?

8. Please provide the CCG's total expenditure on Level 3 neuro-rehabilitation placements (as per Q.7) during the financial year.

9. Please could you provide the number of adults funded by the CCG requiring neuro-palliative care in a nursing/care home.

10. Please provide the CCG's total expenditure on neuro-palliative placements (as per Q.9) during the financial year.

11. Please provide a list of the providers that you commissioned the neuro-rehabilitation Level 3 services with.

13. How many individuals as per Q.1 where on placements outside the boundaries of your CCG (i.e. out of area placement)?

Click here for Response

Click here for Attachment

01/03/2017 535/17

How many contracts the NHS Southern Derbyshire CCG has awarded to private health providers in the past five years to provide NHS walk in centre services?

Click here for Response
01/03/2017 536/17 

Please advise if the CCG or any representative of the CCG provided a reference, verbal or written (or any other form of assurance, written or verbal) regarding Steve Trenchard former CEO of Derbyshire Healthcare NHS Foundation Trust, to Pennine Care NHS Foundation Trust, when Pennine Care was seeking to appointment him as a “consultant project director’.

Please also advise what action the CCG took in response to the Employment Tribunal finding against Derbyshire Healthcare NHS Foundation Trust in the case of Helen Marks, who was sexually harassed and found to have been mistreated and wrongfully dismissed, and what assurance the CCG put in place after that ET judgment to help safeguard against future serious failures of governance at that trust.

Click here for Response
02/03/2017 537/17

1. Does NHS Southern Derbyshire CCG offer patients seven-day, 8-8 access to routine GP appointments?

2. If no, please specify extended-hours opening times for routine GP appointments?

3. How many patients can access this scheme?

4. What is the annual cost of the scheme to the CCG?

5. How much of this funding is spent on GP locums?

6. What (%) take up is there of evening/Saturday/Sunday appointments respectively?

Click here for Response
02/03/2017 538/17

1. Please can you tell me how many Serious Untoward Incidents each CCG you are responsible for has recorded relating to your 111 service provider in:

a. 2014/15
b. 2015/16
c. 2016/17

2. Please also specify the name of the 111 provider.

3. Where the provider has changed in the past three years, please specify the SUIs under the previous contract.

4. Please can you also attach any annual (or quarterly) reports of these incidents produced by the CCG (or NHS 111 provider if held) since 2015.

Click here for Response
03/03/2017 539/17

1. How much has your CCG(s) spent on mental health services in 2015/16 and 2016/17?

2. How much has your CCG(s) budgeted for mental health services in 2017/18 and 2018/19?

3. How much did your CCG(s) spend on children and young people’s mental health services in 2014/15?

4. In 2016/17 how much money was spent on the following services, as outlined in the Five Year Forward View for Mental Health Implementation Plan, released by NHS England in July. If possible, please could you break down the CCG’s spending in a similar way?

a. Children and young people’s mental health services (page 9)
i. CYP Mental Health
ii. Eating disorders

b. Perinatal mental health services (page 14)
i. Perinatal community development fund

c. Adult mental health services
i. Common mental health problems (page 18)
ii. Community, acute and crisis care (page 24)

d. Health and Justice: Liaison and diversion services (page 33)

Click here for Response

Click here for Attachment

07/03/2017 540/17

Can you please confirm how much money is spent when externally contracting care out to the private sector in delivering care to people with a Learning Disability in:
a. Supported living capacity
b. Residential capacity 

Would it be possible to obtain figure for 2015, 2016 and estimated spend for 2017?

Click here for Response
10/03/2017 541/17

1. The date when honey wound dressings appeared on your formulary.

2. How many you have purchased since then.

3. Which company's honey dressings you purchase.

4. Reasons for the addition to the formulary.

5. If any honey products have been swapped from one manufacturer to another.

6. If so, when this changed occurred and why it occurred.

Click here for Response
10/03/2017 542/17

1. Is your CCG routinely funding the provision of bisphosphonates for all eligible women to reduce the risk of their primary breast cancer spreading to other parts of the body? Eligible women are defined as all postmenopausal women with primary breast cancer diagnosed within the last 6 months.

NB: This question does not apply to the provision of bisphosphonates for other indications, whether in breast cancer or another disease.

2. If you are routinely funding the provision of bisphosphonates to reduce the risk of primary breast cancer spreading to other parts of the body, but have not defined your eligible population as all postmenopausal women with primary breast cancer diagnosed within the last 6 months, how have you defined your eligible population? For example, is it risk stratified.

3. If you are routinely funding the provision of bisphosphonates to reduce the risk of primary breast cancer spreading to other parts of the body:
a. Which drug or drugs are you funding (e.g. zoledronic acid, ibandronate, clodronate)?
b. What proportion of patients receiving treatment with bisphosphonates are receiving zoledronic acid (regardless of whether they have received it once, or for the whole course of the treatment)?

4. If you are not routinely funding the provision of bisphosphonates to reduce the risk of primary breast cancer spreading to other parts of the body:
a. What are your reasons for not doing so?
b. Have you considered doing so, and who was involved in this decision-making process?

Part B - Faslodex (fulvestrant)

5. Is your CCG routinely funding Faslodex (fulvestrant) for women with hormone receptor positive locally advanced and metastatic breast cancer?

6. If you are not routinely funding the provision of Faslodex (fulvestrant) for women with hormone receptor positive locally advanced and metastatic breast cancer:
a. What are your reasons for not doing so?
b. Have you considered doing so, and who was involved in this decision-making process?

Part C - Reconstructive breast surgery – procedure limits

7. Does your CCG have any policy or guidance in place that means that reconstructive breast surgery for breast cancer is procedure limited? This means that there is a limit on the number of reconstructive surgical procedures that a breast cancer patient can have. 

8. If your CCG has a policy or guidance in place limiting the number of reconstructive surgical procedures that a breast cancer patient can have:
a. Please provide a copy of the policy or guidance, or details of it.
b. How long has the policy or guidance been in place?

9. If your CCG does not have a policy or guidance in place limiting the number of reconstructive surgical procedures that a breast cancer patient can have:
a. Has it had any discussions on introducing such a policy or guidance?
b. Does it plan to introduce such a policy or guidance in the future?

Part D - Reconstructive breast surgery – time limits 

10. Does your CCG have any policy or guidance in place that means that reconstructive breast surgery for breast cancer is time limited? This means that a patient can only have reconstructive surgery for breast cancer within a certain period of time.

11. If your CCG has a policy or guidance in place putting a time limit on reconstructive breast surgery for breast cancer:
a. Please provide a copy of the policy or guidance, or details of it.
b. How long has the policy or guidance been in place?

12. If your CCG does not have a policy or guidance in place putting a time limit on reconstructive breast surgery for breast cancer:
a. Has it had any discussions on introducing such a policy or guidance?
b. Does it plan to introduce such a policy or guidance in the future?

Part E - Balancing breast surgery

18. Does your CCG have any policy or guidance in place restricting balancing breast surgery for breast cancer patients? Balancing breast surgery is when surgery is undertaken on the opposite breast (to that which was treated for breast cancer) in order to make the breasts symmetrical.

19. If your CCG has a policy or guidance in place restricting balancing breast surgery for breast cancer patients:
a. Please provide a copy of the policy or guidance or details of it.
b. How long has the policy or guidance been in place?

20. If your CCG does not have a policy or guidance in place restricting balancing breast surgery for breast cancer patients:
a. Has it had any discussions on introducing such a policy or guidance?
b. Does it plan to introduce such a policy or guidance in the future?

Click here for Response
10/03/2017 543/17

1. A list of all providers that the CCG commissions for the provision of clinical ophthalmology services (where these are defined as including but not limited to NHS trust and FT services, independent sector provider services, AQP services, community ophthalmology services, enhanced optical/optometry/ophthalmology services, CATS/CAS/interface services, referral management/triage services and any other services related to problems of vision).

2. The current clinical ophthalmology contract(s) start and contract(s) end dates with each provider and the procurement method used to procure each contract.

3. The overall expenditure and associated activity levels of the clinical ophthalmology contract(s) in the financial year 2015-16, (a) in total and (b) broken down by contract.

4. The quality requirements associated with each clinical ophthalmology contract (and any performance data held on them).

5. A count of outpatient first attendances, follow-up attendances and outpatient procedures for Treatment Function codes 130 and 216 in each financial year 2013-14, 2014-15 and 2015-16, broken down by HRG code, and further broken down by service provider.

6. A count of admitted patient care episodes for Treatment Function codes 130 and 216 in each financial year 2013-14, 2014-15 and 2015-16, broken down by HRG code, and further broken down by service provider.

Click here for Response

Click here for Attachment

10/03/2017 544/17

1. The name of the current provider of your IAPT service

2. The date on which the current contract began

3. The date on which the current contract is due to expire

4. The date on which the contract is due to be advertised for re-tender

5. The contract’s estimated annual value at the last point that it was tendered

6. Whether your current IAPT service contract is run as an AQP or block contract

7. Whether your current IAPT service have been subject to any Performance Notices

8. What type of system your current IAPT contract uses (i.e. IAPTus, PCmis, etc.)

Click here for Response
10/03/2017 545/17

1. In your CCG cluster, is there an Electronic Palliative Care Coordination (EPaCCS) in place? For how long?

2. Can you describe how does it work?

3. What is the coverage -among primary care, secondary care, hospices and community services-?

4. Have interoperability issues (different organisations use distinct software) been addressed, and how?

Click here for Response
14/03/2017 546/17

Please could you let me know the names and email addresses for your:

  • Head of Research
  • Head of Analysis
  • Head of Intelligence
  • Head of Performance
Click here for Response
15/03/2017 547/17

1. As of 1st February 2017 or the latest known date, how many residents in your CCG area have one of the following neurological conditions, as specified? If possible, please break this information down by age. If not possible, please provide the total for each condition.

2. What services are provided/commissioned by the CCG for individuals with the neurological conditions specified in this FOIA request in the CCG area? How many people were accessing these services on 2nd January 2017? If it is not possible to state figures for this date, please use the latest date known and state what date this is.

3a. If someone who resides in your CCG area has a neurological condition as specified in this FOIA request, is there a single service or individual that is responsible for coordinating their care across health and social care services?

If “Yes” please proceed to 3b.
If “No” or “Don’t know” please proceed to question 4.

3b. Please tick one box below to show which individual service in your CCG area provides coordination of people’s care across health and social care. (If there are multiple services that provide such coordination, please tick “No - there are multiple coordination services in the CCG area, not a single one” above and then proceed to question 4.)

4a. Does your CCG specifically commission multidisciplinary teams (MDT) to manage neurological conditions?

If yes, please go to 4b. If no, please go to question 5.

4b. Please specify which neurological conditions the MDT(s) you commission work with.

4c Which professionals are included in MDTs in your area? (If you have different groups of professionals included in different MDTs in your CCG, please tick for any professionals that are included in any MDTs in your area.)

5. How many residents with one of the neurological conditions specified in this FOIA request in your CCG area are in an older people’s nursing or care home (i.e., not a specialist residential neurological centre for people as defined in question 2) broken down by age group, as of 2nd January 2017?  If it is not possible to provide figures for this date, please use the most recent date known and state what this date is.

6. As of 2nd January 2017, how many individuals with a neurological condition as specified by this FOIA request from your CCG were you paying for to be placed in a residential setting in an “out of area placement” in a non-neighbouring CCG? (I.e. a CCG that is not your own and is also not an adjacent CCG to your own.)

7. As of 2nd January 2017, how many people with one of the neurological conditions specified in this FOIA request in your CCG area are supported by a personal health budget?

8. Do you have a local outcome framework for any of the following neurological conditions?

Click here for Response

Click here for Attachment

20/03/2017 548/17

1. Please provide the organisation’s total expenditure on Continued Healthcare (CHC) split by the following settings for 2015/16:

a. Nursing Homes
b. Care Homes
c. Domiciliary Care
d. Other 

2. Please provide the organisation’s total expenditure on CHC by the following areas in 2015/16:

a. Prisons
b. Military 

3. Do you collaborate with any CCGs?  If so, please provide:

a. A list of the CCGs in your collaboration
b. The name of the lead CCG 

4. Please describe how the CCG manages:

a. Personal health budgets
b. Direct payments

5. Please provide the organisation’s total expenditure on agency staff, split by staffing group for 2015/16:

a. Admin & Clerical
b. Nursing & Midwifery
c. AHPs
d. Medical & Dental
e. Scientific
f. Other (Please specify)
g. TOTAL 

6. Does the organisation use any 3rd party services/software to manage agency workers?  If so, please provide the following information:

a. Provider Name
b. Description of Services
c. Annual Cost to Organisation in 2015/16 (£)
d. Contract End Date
e. Framework used for procurement 

7. Does the CCG outsource any elements of back office financial or HR management?  If so, please provide the following information for all services:

a. Service Provider Name
b. Description of Services
c. Annual Cost to Organisation in 2015/16 (£)
d. Contract End Date 

8. Please provide the following information relating to GP Federations within the CCG patch:

a. GP Federation Name
b. No. of GPs Included
c. Total Combined Income for 2015/16 (£)

Click here for Response

Click here for Attachment

20/03/2017 549/17

1. Does your CCG commission a foot protection service, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

2. If the answer to Q1 is yes, please state the number of podiatrists and orthoptists employed within this service.

3. If the answer to Q1 is yes, is this service led by a podiatrist with specialist training in diabetic foot problems, as recommended by NICE guideline NG19 on ‘Diabetic foot problems: prevention and management’?

4. If the answer to Q1 is no, please provide a reason for this.

Click here for Response
21/03/2017 550/17

1. Please provide a list of all the occasions in which private consultancy firms have been used/paid by the Trust/CCG during the last three financial years, including this year to date (2014/15, 2015/16 and 2016/17). Please break this information down by date of project/contract, cost to the Trust/CCG and the name of the firm. Please also provide an explanation of the reasons/purpose for the use of the consultancy firm.

2. Please provide any details for any contracts/projects agreed with private consultancy firms for the financial year ahead broken down by the same details as above.

Click here for Response
21/03/2017 551/17

1. Could you set out your current IVF policy?

2. How much money have you spent on IVF in the years 2013/14, 2014/15 and 2015/16?

For each year, how many people received IVF treatment and, of that number how many resulted in pregnancy, no pregnancy, cancelled or awaiting results?

3. What is your estimated funding gap for the years 2015/16 2016/17 2017/18 and 2019/20?

4. Is the funding gap affecting your ability to fund fertility treatments?

And more broadly, do you think IVF provision by the NHS is unsustainable in light of funding pressures?

5. Have you held a public consultation on IVF provision in your local area? If you have held a consultation can you provide the details of the questions you asked and the decision you made in regard to services?

6. If you answered no to question 5, do you have any plans to hold a public consultation on IVF provision?

If so, can you detail the proposed scope of that consultation and the options you will offer the local community in regards to service?

7. If you answered no to question 6 will you rule out running a consultation in 2017/18, 2018/19 and/or 2019/20?

Click here for Response
22/03/2017 552/17

1. How many job roles with a remit of working in/for the STP have been created? Please provide the job title, job description and annual remuneration for the role.

2. How many members of staff of other NHS organisations have been seconded to work with the STP? Please provide job title, job description and remuneration for the role and length of involvement.

3. How many external/private staff are working for the STP? Please provide their job role, where they are employed from, description and the remuneration they are being given and length of involvement.

Click here for Response

Click here for Attachment 1

Click here for Attachment 2

23/03/2017 553/17

1. Is hypoallergenic formula available on prescription for infants with CMPA (Cow’s Milk Protein Allergy) by your Commissioning Group?

2. Can you confirm that you will continue to provide this vitally important food for special medical purposes?

Click here for Response
23/03/2017 554/17

1. What is the annual cost for the CCG of providing oxygen therapy to patients with cluster headaches (Clinical code 18 on the NHS Home Oxygen Order Form (HOOF) :

a. as a total figure
b. per patient

2. What is the annual cost to the CCG (as a total figure) of providing:

a. Equipment hire and the supply of cylinders and refills
b. The provision of patient equipment training
c. The provision of home risk assessments 

3. How many patients with cluster headache only have been provided with home oxygen therapy in each of the last 5 years

4. Is the supply of home oxygen VAT exempt?

5. Do invoices sent to the payer include VAT at the standard rate of 20%?

Click here for Response
24/03/2017 555/17

1. How many patients have been referred for fertility treatment (excluding investigations, but including donor insemination, intrauterine insemination, in vitro fertilisation and intracytoplasmic sperm injection) in the past 12 months in your CCG area?

2. Please detail which fertility providers these patients have been referred to, i.e. please provide the numbers of patients that have been referred to which providers.

Click here for Response
24/03/2017 556/17

Please could you provide a structure chart of your finance and procurement departments via e-mail, where possible including the names of each staff members.

Click here for Response

Click here for Attachment

24/03/2017 557/17

Can you please confirm whether training is a condition of PHB funding in your area and if so, how it should be delivered, eg. Open course (specific companies?), in-house, e-learning (specific companies?), NHS, linked in with Social Services. Also, it would be useful to know if the requirements are mapped to any standards, eg. Care Certificate, CQC.

Click here for Response
27/03/2017 558/17

1. Do you currently provide a community eating disorders service which meets the requirements of the NHS England access and waiting times standards for children and young people (CYP) with eating disorders (ED)?

If so:

1.2 What are the names and locations (postcode) of these services?

1.3 Which model - Model A or Model B - from the commissioning guide, has been followed?

2. Please provide figures for the following:

2.1 How much money has been allocated to your CYP community ED services for the following financial years: 2014-15, 2015-16, 2016-17, 2017-2018?

2.2 What was your actual spend on your CYP community ED services for the following financial years: 2014-2015, 2015-2016, 2016-17(to date); and what is your planned spend for 2017-18?

2.3 Please provide a breakdown of what aspects of your service this money has been spent on for the years 2014-15, 2015-16, and 2016-17(to date).

Click here for Response

Click here for Attachment

28/03/2017 559/17

Would it be possible to request a copy of the organisation chart for NHS Southern Derbyshire CCG? I’m particularly interested in the areas of Senior Management, Information, Performance, Finance, Data, Analytics & IT.

Click here for Response

Click here for Attachment

31/03/2017 560/17

I am requesting the information for the years (i) 2014/15, (ii) 2015/16, and (iii) 2016/17, unless otherwise stated.

1. How many adults were assessed for eligibility for NHS Continuing Healthcare in your area in each of the last three years?

2. Of all adults who were assessed for eligibility for NHS Continuing Healthcare in your area, how many were found to be eligible in each of the last three years?

3. In total, how many adults have received NHS Continuing Healthcare in your area in each of the last three years?

4. How many adults who received NHS Continuing Healthcare in your area had a personal health budget in each of the last three years? 

5. Of all adults who received NHS Continuing Healthcare in your area, what percentage had a personal health budget in each of the last three years?

6. According to NHS England, “A decision about eligibility should usually be made within 28 days of it being decided that the person needs a full assessment for NHS Continuing Healthcare.”

In your CCG, what was a) the average and b) the longest waiting time between the decision that the person needs a full assessment for NHS Continuing Healthcare, and a decision about eligibility, in each of the last three years?

7. How many adults in receipt of NHS Continuing Healthcare had their CHC package (a) withdrawn and (b) reduced in each of the last three years? 

8. Has your CCG made changes to the criteria for eligibility for NHS Continuing Healthcare in the last 12 months?  If so, please provide details.

9. What was the average value of an adult’s NHS Continuing Healthcare package in your area in each of the last three years?

10. What was the average value of a personal health budget in your area in each of the last three years?

Click here for Response

Click here for Attachment

Last modified: 27/04/2017